PBYI — PUMA BIOTECHNOLOGY INC

Ownership history in RITHOLTZ WEALTH MANAGEMENT  ·  8 quarters on record

This page tracks every 13F SEC filing in which RITHOLTZ WEALTH MANAGEMENT reported a position in PUMA BIOTECHNOLOGY INC (PBYI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.08% (2025 Q4)
Avg. % of fund
0.02%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 694,001 +223,234 +47.4% 0.08% $4.1M $5.95
2025 Q3 ADDED 470,767 +273,782 +139.0% 0.05% $2.5M $5.31
2025 Q2 ADDED 196,985 +176,857 +878.7% 0.01% $676K $3.43
2024 Q4 REDUCED 20,128 -1,472 -6.8% 0.00% $61K $3.05
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PBYI price (monthly, adj. close)

Other funds also holding PBYI

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 8.33% GLOBEFLEX CAPITAL L P 3Y 7Y 0.41% Verdad Advisers, LP 3Y 0.38% VIRTUS ADVISERS, LLC 3Y 7Y 0.13% C2C Wealth Management, LLC 3Y 0.12% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.11% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.1% Round Rock Advisors LLC 3Y 0.09% EntryPoint Capital, LLC 0.08% Baron Wealth Management LLC 0.06%
← Back to RITHOLTZ WEALTH MANAGEMENT Holdings